- Home
- SCKT vs SNSE Comparison
SCKT vs SNSE Comparison
Compare SCKT & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- SNSE
- Stock Information
- Founded
- SCKT 1992
- SNSE 2005
- Country
- SCKT United States
- SNSE United States
- Employees
- SCKT N/A
- SNSE N/A
- Industry
- SCKT Computer Manufacturing
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- SNSE Health Care
- Exchange
- SCKT Nasdaq
- SNSE Nasdaq
- Market Cap
- SCKT 9.3M
- SNSE 9.3M
- IPO Year
- SCKT 1995
- SNSE 2021
- Fundamental
- Price
- SCKT $1.13
- SNSE $8.69
- Analyst Decision
- SCKT
- SNSE Strong Buy
- Analyst Count
- SCKT 0
- SNSE 3
- Target Price
- SCKT N/A
- SNSE $86.67
- AVG Volume (30 Days)
- SCKT 17.3K
- SNSE 12.2K
- Earning Date
- SCKT 07-30-2025
- SNSE 08-05-2025
- Dividend Yield
- SCKT N/A
- SNSE N/A
- EPS Growth
- SCKT N/A
- SNSE N/A
- EPS
- SCKT N/A
- SNSE N/A
- Revenue
- SCKT $17,750,643.00
- SNSE N/A
- Revenue This Year
- SCKT $8.62
- SNSE N/A
- Revenue Next Year
- SCKT N/A
- SNSE N/A
- P/E Ratio
- SCKT N/A
- SNSE N/A
- Revenue Growth
- SCKT 0.29
- SNSE N/A
- 52 Week Low
- SCKT $0.91
- SNSE $5.00
- 52 Week High
- SCKT $1.72
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- SCKT 47.51
- SNSE 63.87
- Support Level
- SCKT $1.08
- SNSE $5.86
- Resistance Level
- SCKT $1.19
- SNSE $8.74
- Average True Range (ATR)
- SCKT 0.05
- SNSE 0.75
- MACD
- SCKT -0.00
- SNSE 0.25
- Stochastic Oscillator
- SCKT 35.71
- SNSE 88.54
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).